Identifying and Managing Patients with Elevated Breast Cancer Risk Presenting for Screening Mammography

2021 Onega, 2014, Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level, Cancer, 120, 2955, 10.1002/cncr.28771 McCarthy, 2020, Performance of breast cancer risk-assessment models in a large mammography cohort, J Natl Cancer Inst, 112, 489, 10.1093/jnci/djz177 Brentnall, 2019, A case-control study to add volumetric or clinical mammographic density into the Tyrer-Cuzick breast cancer risk model, J Breast Imaging, 1, 99, 10.1093/jbi/wbz006 Brentnall, 2018, Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density, JAMA Oncol, 4, 10.1001/jamaoncol.2018.0174 Saslow, 2007, American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography, CA Cancer J Clin, 57, 75, 10.3322/canjclin.57.2.75 Monticciolo, 2018, Breast cancer screening in women at higher-than average risk: Recommendations from the ACR, J Am Coll Radiol, 15, 408, 10.1016/j.jacr.2017.11.034 Wang, 2021, Supplemental screening for patients at intermediate and high risk for breast cancer, Radiol Clin North Am, 59, 67, 10.1016/j.rcl.2020.09.006 Sorin, 2018, Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts, AJR Am J Roentgenol, 211, W267, 10.2214/AJR.17.19355 Kim, 2021, Assessing risk of breast cancer: A review of risk prediction models, J Breast Imaging, 3, 144, 10.1093/jbi/wbab001 Visvanathan, 2013, Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline, J Clin Oncol, 31, 2942, 10.1200/JCO.2013.49.3122 Melnikow, 2016, Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. Preventive Services Task Force, Ann Intern Med, 164, 268, 10.7326/M15-1789 Cintolo-Gonzalez, 2017, Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications, Breast Cancer Res Treat, 164, 263, 10.1007/s10549-017-4247-z Laws, 2021, Implementation of a high-risk breast clinic for comprehensive care of women with elevated breast cancer risk identified by risk assessment models in the community, JCO Oncol Pract, 17, e217, 10.1200/OP.20.00256 Smith, 2016, Factors affecting uptake and adherence to breast cancer chemoprevention: A systematic review and meta-analysis, Ann Oncol, 27, 575, 10.1093/annonc/mdv590